The vaccine not only prevents severe disease, but also effectively blocks viral transmission in animal models, offering a promising strategy for pandemic preparedness against future coronavirus threats. A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. The vaccine not on

Job Reference Number: C2i124-RP1 The Centre for Immunology & Infection (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive innovation in pub

Job Reference Number: C2i123-RP3 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i

Job Reference Number: C2i122-Admin The Centre for Immunology & Infection Limited (C2i) is a premier research institute focused on advancing biomarker discovery and the development of next-generation vaccines and therapeutic strategies. Founded through a strategic partnership of over 20 years between the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) and the Institut Pasteur in Paris, C2i integrates world-class expertise in biomedical science to drive innovat

Job Reference Number: C2i121-RP4 The Centre for Immunology & Infection (C2i) uses novel technology platforms for biomarker discovery and the development of new vaccine and therapeutic strategies.   It is the fruit of a long-standing partnership of more than 20 years between the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) and the Institut Pasteur, Paris, two major international leaders combining their expertise to establish this centre of excellence.   C2i